MaxCyte, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $24.00K, a 20.00% increase year-over-year.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $5.00K, a 98.69% decline year-over-year.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $14.00K, a 93.86% decline year-over-year.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $20.00K, a 95.54% decline year-over-year.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $432.00K, a 72.95% decline from fiscal 2024.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.60M, a 14.78% decline from fiscal 2023.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.87M, a 35.11% decline from fiscal 2022.
- MaxCyte, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $2.89M, a 20.47% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $432.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $20.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $383.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $1.60M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $228.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $448.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $703.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $1.87M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $37.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $157.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $1.46M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $2.89M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $444.40K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $325.50K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $892.60K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $3.63M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $334.70K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $52.20K 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $2.04M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $401.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $285.90K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $132.70K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |